The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis

被引：0
|
作者：
Christian S. Thudium
Anne C. Bay-Jensen
Suntara Cahya
Ernst R. Dow
Morten A. Karsdal
Alisa E. Koch
Wenling Zhang
Robert J. Benschop
机构：
[1] Nordic Bioscience,
[2] Biomarkers and Research,undefined
[3] Eli Lilly and Company,undefined
来源：
Arthritis Research & Therapy | / 22卷
关键词：
Biomarkers; Baricitinib; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis
    Hodge, J. A.
    Kawabata, T. T.
    Krishnaswami, S.
    Clark, J. D.
    Telliez, J. -B.
    Dowty, M. E.
    Menon, S.
    Lamba, M.
    Zwillich, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 318 - 328
  • [22] Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection
    Akbarzadeh-Khiavi, Mostafa
    Torabi, Mitra
    Rahbarnia, Leila
    Safary, Azam
    INFECTION, 2022, 50 (02) : 295 - 308
  • [23] Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection
    Mostafa Akbarzadeh-Khiavi
    Mitra Torabi
    Leila Rahbarnia
    Azam Safary
    Infection, 2022, 50 : 295 - 308
  • [24] Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE
    Li, Zhan-Guo
    Hu, Jian-Kang
    Li, Xiang-Pei
    Yang, Yue
    Li, Xing-Fu
    Xu, Jian-Hua
    Zhang, Xiao
    Xu, Jian
    Bao, Chun-De
    He, Dong-Yi
    Li, Zhi-Jun
    Wang, Guo-Chun
    Zuo, Xiao-Xia
    Liu, Yi
    Xiao, Zheng-Yu
    Chen, Jin-Wei
    Xin, Xia-Fei
    Li, Jing-Yang
    Jiang, Lin-Di
    Liu, Meng-Ru
    Ji, Fei
    Li, Chen-Ge
    ADVANCES IN THERAPY, 2021, 38 (01) : 772 - 781
  • [25] Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE
    Zhan-Guo Li
    Jian-Kang Hu
    Xiang-Pei Li
    Yue Yang
    Xing-Fu Li
    Jian-Hua Xu
    Xiao Zhang
    Jian Xu
    Chun-De Bao
    Dong-Yi He
    Zhi-Jun Li
    Guo-Chun Wang
    Xiao-Xia Zuo
    Yi Liu
    Zheng-Yu Xiao
    Jin-Wei Chen
    Xia-Fei Xin
    Jing-Yang Li
    Lin-Di Jiang
    Meng-Ru Liu
    Fei Ji
    Chen-Ge Li
    Advances in Therapy, 2021, 38 : 772 - 781
  • [26] Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials
    Chen, Ying-Chou
    Yoo, Dae Hyun
    Lee, Chang Keun
    Li, Ko-Jen
    Won, Ji-Eon
    Wu, Wen-Shuo
    Zhong, Jinglin
    Nicolay, Claudia
    Walls, Chad Daniel
    Tanaka, Yoshiya
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (01) : 65 - 73
  • [27] Comparative effectiveness of biological disease-modifying antirheumatic drugs and Janus kinase inhibitor monotherapy in rheumatoid arthritis
    Onishi, Akira
    Yamada, Hirotaka
    Yamamoto, Wataru
    Watanabe, Ryu
    Hara, Ryota
    Katayama, Masaki
    Okita, Yasutaka
    Maeda, Yuichi
    Amuro, Hideki
    Son, Yonsu
    Yoshikawa, Ayaka
    Hata, Kenichiro
    Hashimoto, Motomu
    Saegusa, Jun
    Morinobu, Akio
    RHEUMATOLOGY, 2023, 63 (11) : 3065 - 3073
  • [28] Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study
    Smolen, Josef S.
    Xie, Li
    Jia, Bochao
    Taylor, Peter C.
    Burmester, Gerd
    Tanaka, Yoshiya
    Elias, Ayesha
    Cardoso, Anabela
    Ortmann, Rob
    Walls, Chad
    Dougados, Maxime
    RHEUMATOLOGY, 2021, 60 (05) : 2256 - 2266
  • [29] Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study
    Caporali, Roberto
    Taylor, Peter C.
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Bello, Natalia
    Zaremba-Pechmann, Liliana
    Fang, Ying
    Dougados, Maxime
    RHEUMATOLOGY, 2024, 63 (10) : 2799 - 2809
  • [30] Opportunistic infections associated with Janus kinase inhibitor treatment for rheumatoid arthritis: A structured literature review
    Winthrop, Kevin
    Isaacs, John
    Calabrese, Leonard
    Mittal, Deepali
    Desai, Supriya
    Barry, Jane
    Strengholt, Sander
    Galloway, James
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 58
12345